NEW YORK, July 31 (Reuters) - Allergan Inc posted a 23 percent rise in second-quarter earnings Friday, topping Wall Street expectations, as lower research and development spending helped offset ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback